What happened
Aprogen Biologics disclosed convertible bonds to raise US$6.65M, about 39.2% of its market value.
For context, this raise equals about 39.2% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$6.65M |
| vs. market value | 39.2% |
| Filed | 2026-05-21, Material event report (convertible bonds) |
| Source | DART rcept 20260521000775 → open original filing |
Source: DART. Information only, not investment advice.